Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Cancer Discovery
|
July 28, 2019
The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC
Pablo E Hollstein, Lillian J Eichner, Sonja N Brun, et al.
Travel Medicine and Infectious Disease
|
May 19, 2022
Telemedicine for international travelers through a Smartphone-based monitoring platform (Trip Doctor®)
N Rodriguez-Valero, Mj Ledesma Carbayo, D Camprubí-Ferrer, et al.
Alimentary Pharmacology & Therapeutics
|
December 8, 2010
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
C Taxonera, J Estellés, I Fernández-Blanco, et al.
Journal of Medicinal Chemistry
|
April 23, 2014
Optimization of antitrypanosomatid agents: identification of nonmutagenic drug candidates with in vivo activity
Guzmán Álvarez, Javier Varela, Pablo Márquez, et al.
Revista Espanola De Enfermedades Digestivas
|
November 20, 2020
Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn's disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain
Helena Martínez-Lozano, José Miranda-Bautista, Yago González-Lama, et al.
Journal of Crohn'S & Colitis
|
September 11, 2013
Disease severity in familial cases of IBD
M Andreu, L Márquez, E Domènech, et al.
Digestive Diseases and Sciences
|
January 13, 2024
IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management
P Vega, J M Huguet, E Gómez, et al.
Revista Espanola De Enfermedades Digestivas
|
July 3, 2004
Predictors of response to infliximab in patients with fistulizing Crohn's disease
M Luna-Chadid, J L Pérez Calle, J L Mendoza, et al.
Biochemical Pharmacology
|
September 25, 2016
Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximab
B Hernández-Breijo, M Chaparro, D Cano-Martínez, et al.
Digestive Diseases and Sciences
|
September 13, 2013
Health care costs of complex perianal fistula in Crohn's disease
M Chaparro, C Zanotti, P Burgueño, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Cancer Discovery
|
July 28, 2019
The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC
Pablo E Hollstein, Lillian J Eichner, Sonja N Brun, et al.
Travel Medicine and Infectious Disease
|
May 19, 2022
Telemedicine for international travelers through a Smartphone-based monitoring platform (Trip Doctor®)
N Rodriguez-Valero, Mj Ledesma Carbayo, D Camprubí-Ferrer, et al.
Alimentary Pharmacology & Therapeutics
|
December 8, 2010
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
C Taxonera, J Estellés, I Fernández-Blanco, et al.
Journal of Medicinal Chemistry
|
April 23, 2014
Optimization of antitrypanosomatid agents: identification of nonmutagenic drug candidates with in vivo activity
Guzmán Álvarez, Javier Varela, Pablo Márquez, et al.
Revista Espanola De Enfermedades Digestivas
|
November 20, 2020
Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn's disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain
Helena Martínez-Lozano, José Miranda-Bautista, Yago González-Lama, et al.
Journal of Crohn'S & Colitis
|
September 11, 2013
Disease severity in familial cases of IBD
M Andreu, L Márquez, E Domènech, et al.
Digestive Diseases and Sciences
|
January 13, 2024
IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management
P Vega, J M Huguet, E Gómez, et al.
Revista Espanola De Enfermedades Digestivas
|
July 3, 2004
Predictors of response to infliximab in patients with fistulizing Crohn's disease
M Luna-Chadid, J L Pérez Calle, J L Mendoza, et al.
Biochemical Pharmacology
|
September 25, 2016
Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximab
B Hernández-Breijo, M Chaparro, D Cano-Martínez, et al.
Digestive Diseases and Sciences
|
September 13, 2013
Health care costs of complex perianal fistula in Crohn's disease
M Chaparro, C Zanotti, P Burgueño, et al.
Page
of 9